何氏眼科 - Financials

何氏眼科 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
+Revenue	1.1B	1.2B	955.0M	962.0M	838.0M	746.0M	614.0M	476.0M
Revenue Growth %	-7.5%	24.1%	-0.7%	14.8%	12.3%	21.5%	29.0%	--
Total Revenue	1.1B	1.2B	955.0M	962.0M	838.0M	746.0M	614.0M	476.0M
Cost Of Revenue	673.0M	690.0M	588.0M	575.0M	474.0M	423.0M	356.0M	284.0M
+Gross Profit	423.0M	495.0M	367.0M	387.0M	364.0M	323.0M	258.0M	192.0M
Gross Margin %	38.6%	41.8%	38.4%	40.2%	43.4%	43.3%	42.0%	40.3%
Total Operating Cost	1.1B	1.1B	890.0M	838.0M	703.0M	638.0M	527.0M	427.0M
Selling Expenses	182.0M	178.0M	138.0M	123.0M	107.0M	103.0M	75.2M	58.5M
Admin Expenses	219.0M	214.0M	163.0M	127.0M	117.0M	110.0M	90.5M	78.5M
Rd Expenses	18.1M	12.6M	1.3M	1.2M	1.6M	1.6M	2.2M	2.3M
Finance Expenses	-7.4M	-15.4M	-8.2M	4.5M	-2.6M	-6.6M	-7.8M	464,700
+Operating Income	6.2M	107.0M	71.1M	129.0M	143.0M	124.0M	89.7M	70.2M
Operating Margin %	0.6%	9.0%	7.4%	13.4%	17.1%	16.6%	14.6%	14.7%
Non Operating Income	208,700	843,200	1.3M	7.9M	6.7M	2.2M	1.9M	2.0M
Non Operating Expenses	4.7M	2.1M	934,800	1.0M	1.5M	1.9M	1.9M	649,600
Investment Income	453,400	3.2M	1.1M	--	237,700	--	10,800	15.9M
Fair Value Change Income	993,000	--	--	--	--	--	--	-711,400
Asset Disposal Income	1.4M	3.5M	-64,700	-305,200	-57,300	13.2M	-5,900	-5,300
Asset Impairment Loss	1.7M	1.2M	419,100	462,700	423,100	1.7M	7.7M	-32,900
Other Income	3.4M	5.3M	5.1M	5.3M	7.1M	3.6M	3.1M	5.1M
Income Before Tax	1.6M	105.0M	71.5M	136.0M	148.0M	124.0M	89.7M	71.5M
Income Tax	36.9M	47.6M	39.4M	50.0M	48.2M	43.8M	33.5M	25.8M
+Net Income	-35.3M	57.8M	32.1M	86.4M	100.0M	80.6M	56.2M	45.7M
Net Margin %	-3.2%	4.9%	3.4%	9.0%	11.9%	10.8%	9.1%	9.6%
Net Income Attributable	-27.4M	63.6M	32.6M	86.4M	100.0M	80.6M	56.1M	46.0M
Minority Interest	-7.9M	-5.8M	-486,800	--	--	--	69,200	-323,600
Eps Basic	-0.17	0.40	0.22	0.73	1.10	0.89	0.62	0.53
Eps Diluted	-0.17	0.40	0.22	0.73	1.10	0.89	0.62	0.53

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash And Equivalents	767.0M	1.6B	1.6B	699.0M	613.0M	543.0M	491.0M	463.0M
Trading Financial Assets	502.0M	--	--	--	--	--	--	--
Accounts Receivable	36.9M	51.4M	31.5M	30.8M	28.0M	25.8M	23.4M	25.6M
Notes And Accounts Receivable	36.9M	51.4M	31.5M	30.8M	28.0M	25.8M	23.4M	25.6M
Prepayments	15.8M	25.3M	14.7M	22.4M	39.4M	33.6M	26.3M	18.6M
Inventory	75.0M	85.4M	84.1M	72.9M	70.5M	72.8M	70.4M	53.4M
Total Current Assets	1.4B	1.8B	2.0B	830.0M	758.0M	680.0M	616.0M	565.0M
Long Term Equity Investment	120.0M	--	--	--	--	--	--	--
Fixed Assets	--	210.0M	197.0M	225.0M	215.0M	190.0M	156.0M	150.0M
Fixed Assets Total	300.0M	210.0M	197.0M	225.0M	215.0M	190.0M	156.0M	150.0M
Construction In Progress	--	17.9M	7.8M	2.4M	3.4M	3.0M	6.6M	2.6M
Construction In Progress Total	13.2M	17.9M	7.8M	2.4M	3.4M	3.0M	6.6M	2.6M
Intangible Assets	33.6M	35.0M	38.5M	32.0M	22.8M	18.0M	9.3M	8.6M
Long Term Deferred Expenses	86.0M	98.6M	71.7M	79.0M	75.3M	72.1M	51.2M	45.8M
Total Non Current Assets	820.0M	700.0M	623.0M	591.0M	346.0M	310.0M	242.0M	221.0M
Total Assets	2.2B	2.5B	2.6B	1.4B	1.1B	989.0M	858.0M	786.0M
Accounts Payable	59.0M	59.2M	68.1M	57.8M	57.5M	55.0M	49.6M	53.4M
Advance Receipts	--	--	--	--	--	7.6M	6.3M	4.4M
Contract Liabilities	20.6M	21.4M	13.0M	15.2M	11.6M	--	--	--
Total Current Liabilities	169.0M	199.0M	167.0M	161.0M	119.0M	105.0M	86.1M	86.8M
Total Non Current Liabilities	177.0M	212.0M	263.0M	210.0M	21.9M	23.0M	24.7M	9.4M
Total Liabilities	346.0M	411.0M	430.0M	371.0M	141.0M	128.0M	111.0M	96.2M
Paid In Capital	158.0M	158.0M	158.0M	91.1M	91.1M	91.1M	90.0M	7.8M
Capital Reserve	1.7B	1.7B	1.7B	584.0M	584.0M	582.0M	550.0M	633.0M
Surplus Reserve	57.7M	54.1M	47.1M	36.2M	24.5M	11.2M	5,100	5,100
Retained Earnings	61.3M	186.0M	288.0M	339.0M	264.0M	177.0M	108.0M	50.1M
Minority Equity	-87,600	-3.0M	1.9M	--	--	--	--	-719,900
Equity Attributable	1.9B	2.1B	2.2B	1.1B	963.0M	862.0M	747.0M	690.0M
Total Equity	1.9B	2.1B	2.2B	1.1B	963.0M	862.0M	747.0M	690.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash From Sales	1.2B	1.2B	1.0B	995.0M	861.0M	775.0M	645.0M	485.0M
Tax Refunds Received	--	--	6.0M	--	--	--	--	--
Total Operating Cash Inflow	1.2B	1.3B	1.0B	1.0B	879.0M	788.0M	658.0M	495.0M
Cash Paid For Goods	369.0M	433.0M	350.0M	318.0M	303.0M	287.0M	261.0M	181.0M
Cash Paid To Employees	466.0M	432.0M	345.0M	297.0M	226.0M	221.0M	180.0M	136.0M
Taxes Paid	69.5M	88.2M	80.6M	88.8M	72.0M	66.6M	57.9M	49.4M
Total Operating Cash Outflow	1.0B	1.1B	889.0M	802.0M	709.0M	667.0M	576.0M	427.0M
Operating Cash Flow	156.0M	177.0M	148.0M	214.0M	170.0M	120.0M	81.8M	67.9M
Total Investing Cash Inflow	387.0M	203.0M	--	237,400	18,900	14.7M	2.0M	1.4B
Total Investing Cash Outflow	1.1B	189.0M	249.0M	71.2M	93.2M	111.0M	70.8M	1.1B
Investing Cash Flow	-759.0M	14.0M	-249.0M	-71.0M	-93.1M	-96.8M	-68.8M	248.0M
Dividends And Interest Paid	94.0M	158.0M	72.9M	--	--	--	197,700	--
Total Financing Cash Inflow	--	588,000	1.2B	--	--	30.0M	16.0M	117.0M
Total Financing Cash Outflow	218.0M	242.0M	160.0M	57.7M	6.2M	1.3M	1.8M	7.1M
Financing Cash Flow	-218.0M	-241.0M	1.0B	-57.7M	-6.2M	28.7M	14.2M	110.0M
Net Change In Cash	-821.0M	-50.6M	940.0M	84.9M	70.4M	52.3M	27.2M	426.0M
Ending Cash Balance	766.0M	1.6B	1.6B	698.0M	613.0M	543.0M	491.0M	463.0M
Capex	116.0M	189.0M	49.1M	71.2M	93.2M	111.0M	67.3M	72.7M